Widespread testing and isolation of infected patients is a cornerstone of viral outbreak management, as underscored during the ongoing COVID-19 pandemic. Here, we report a large-area and label-free testing platform that combines surface-enhanced Raman spectroscopy and machine learning for the rapid and accurate detection of SARS-CoV-2. Spectroscopic signatures acquired from virus samples on metal–insulator–metal nanostructures, fabricated using nanoimprint lithography and transfer printing, can provide test results within 25 min. Not only can our technique accurately distinguish between different respiratory and nonrespiratory viruses, but it can also detect virus signatures in physiologically relevant matrices such as human saliva without any additional sample preparation. Furthermore, our large area nanopatterning approach allows sensors to be fabricated on flexible surfaces allowing them to be mounted on any surface or used as wearables. We envision that our versatile and portable label-free spectroscopic platform will offer an important tool for virus detection and future outbreak preparedness.

Label-Free Spectroscopic SARS-CoV-2 Detection on Versatile Nanoimprinted Substrates

https://doi.org/10.1016/j.bios.2022.114008

Surface-enhanced Raman scattering-based immunoassay for severe acute respiratory syndrome coronavirus 2

Coronavirus disease 2019 (COVID-19) initiated global health care challenges such as the necessity for new diagnostic tests. Diagnosis by real-time PCR remains the gold-standard method, yet economical and technical issues prohibit its use in points of care (POC) or for repetitive tests in populations. A lot of effort has been exerted in developing, using, and validating antigen-based tests (ATs). Since individual studies focus on few methodological aspects of ATs, a comparison of different tests is needed. Herein, we perform a systematic review and meta-analysis of data from articles in PubMed, medRxiv and bioRxiv. The bivariate method for meta-analysis of diagnostic tests pooling sensitivities and specificities was used. Most of the AT types for SARS-CoV-2 were lateral flow immunoassays (LFIA), fluorescence immunoassays (FIA), and chemiluminescence enzyme immunoassays (CLEIA). We identified 235 articles containing data from 220,049 individuals. All ATs using nasopharyngeal samples show better performance than those with throat saliva (72% compared to 40%). Moreover, the rapid methods LFIA and FIA show about 10% lower sensitivity compared to the laboratory-based CLEIA method (72% compared to 82%). In addition, rapid ATs show higher sensitivity in symptomatic patients compared to asymptomatic patients, suggesting that viral load is a crucial parameter for ATs performed in POCs. Finally, all methods perform with very high specificity, reaching around 99%. LFIA tests, though with moderate sensitivity, appear as the most attractive method for use in POCs and for performing seroprevalence studies.

https://www.mdpi.com/2075-4418/12/6/1388/pdf?version=1654667092

Performance of Antigen Detection Tests for SARS-CoV-2: A Systematic Review and Meta-Analysis

Probing the mutation independent interaction of DNA probes with SARS-CoV-2 variants through a combination of surface-enhanced Raman scattering and machine learning

The outbreak of COVID-19 caused by SARS-CoV-2 urges the development of rapidly and accurately diagnostic methods. Here, one high-sensitivity and point-of-care detection method based on magnetic SERS biosensor composed of Fe3O4-Au nanocomposite and Au nanoneedles array was developed to detect SARS-CoV-2 directly. Among, the magnetic Fe3O4-Au nanocomposite is applied to capture and separate virus from nasal and throat swabs and enhance the Raman signals of SARS-CoV-2. The magnetic SERS biosensor possessed high sensitivity by optimizing the Fe3O4-Au nanocomposite. More significantly, the on-site detection of inactivated SARS-CoV-2 virus was achieved based on the magnetic SERS biosensor with ultra-low limit of detection of 100 copies/mL during 15 mins. Furthermore, the contaminated nasal and throat swabs samples were identified by support vector machine, and the diagnostic accuracy of 100% was obtained. The magnetic SERS biosensor combined with support vector machine provides giant potential as the point-of-care detection tool for SARS-CoV-2. 

https://doi.org/10.1016/j.snb.2022.131974

High-sensitivity and point-of-care detection of SARS-CoV-2 from nasal and throat swabs by magnetic SERS biosensor

A rapid, on-site, and accurate SARS-CoV-2 detection method is crucial for the prevention and control of the COVID-19 epidemic. However, such an ideal screening technology has not yet been developed for the diagnosis of SARS-CoV-2. Here, we have developed a deep learning-based surface-enhanced Raman spectroscopy technique for the sensitive, rapid, and on-site detection of the SARS-CoV-2 antigen in the throat swabs or sputum from 30 confirmed COVID-19 patients. A Raman database based on the spike protein of SARS-CoV-2 was established from experiments and theoretical calculations. The corresponding biochemical foundation for this method is also discussed. The deep learning model could predict the SARS-CoV-2 antigen with an identification accuracy of 87.7%. These results suggested that this method has great potential for the diagnosis, monitoring, and control of SARS-CoV-2 worldwide.

On-Site Detection of SARS-CoV-2 Antigen by Deep Learning-Based Surface-Enhanced Raman Spectroscopy and Its Biochemical Foundations.

The invention discloses a construction method of a novel coronavirus Raman spectrum data center. The method comprises the following steps: S1, constructing a novel coronavirus structural protein Ramanspectrum database; S2, constructing a novel coronavirus nucleic acid Raman spectrum database; S3, constructing a novel coronavirus particle Raman spectrum database; S4, constructing a Raman spectrumdatabase of a novel coronavirus clinical detection sample; and storing each novel coronavirus Raman spectrum database into a novel coronavirus Raman spectrum detection server to form a novel coronavirus Raman spectrum data center. According to the invention, a set of complete novel coronavirus Raman spectrum database is effectively established, reliable standard data support is provided for the novel coronavirus Raman detection technology, and the accuracy and confidence of a detection result are effectively improved.

Construction method of novel coronavirus Raman spectrum data center

The invention discloses an SERS (Surface Enhanced Raman Scattering) chip for novel coronavirus detection and a preparation method thereof. The SERS chip is of a multi-layer enhanced structure comprising a substrate and a sandwich precursor. The method comprises the following steps of: (1) firstly, depositing the sandwich precursor on the substrate by adopting a magnetron sputtering technology; and(2) carrying out dealloying treatment on the sandwich precursor to obtain the SERS chip. The method is simple in preparation and low in cost, a surfactant does not need to be introduced, large-area uniform preparation can be achieved, virus particles can be specifically captured, collapse of a macrostructure of an alloy system in the dealloying process is avoided, Au-Ag alloy with the Au contentbeing only 1-5 at.% serves as a precursor functional layer, and SERS chips with different channel sizes are prepared. The SERS chip can be applied to the field of on-site rapid detection of the novelcoronavirus.

Wen Jiaxing

Papers

On-Site Detection of SARS-CoV-2 Antigen by Deep Learning-Based Surface-Enhanced Raman Spectroscopy and Its Biochemical Foundations.

Construction method of novel coronavirus Raman spectrum data center

SERS chip for detecting novel coronavirus and preparation method thereof